Cdk5 regulates IP3R1-mediated Ca dynamics and Ca-mediated cell proliferation.

Cell Mol Life Sci

Department of Cell Biology and Anatomy, Arnie Charbonneau Cancer and Alberta Children's Hospital Research Institutes, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.

Published: August 2022

Loss of cyclin-dependent kinase 5 (Cdk5) in the mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) increases ER-mitochondria tethering and ER Ca transfer to the mitochondria, subsequently increasing mitochondrial Ca concentration ([Ca]). This suggests a role for Cdk5 in regulating intracellular Ca dynamics, but how Cdk5 is involved in this process remains to be explored. Using ex vivo primary mouse embryonic fibroblasts (MEFs) isolated from Cdk5 mouse embryos, we show here that loss of Cdk5 causes an increase in cytosolic Caconcentration ([Ca]), which is not due to reduced internal Ca store capacity or increased Ca influx from the extracellular milieu. Instead, by stimulation with ATP that mediates release of Ca from internal stores, we determined that the rise in [Ca] in Cdk5 MEFs is due to increased inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca release from internal stores. Cdk5 interacts with the IP3R1 Ca channel and phosphorylates it at Ser. Such phosphorylation controls IP3R1-mediated Ca release as loss of Cdk5, and thus, loss of IP3R1 Ser phosphorylation triggers an increase in IP3R1-mediated Ca release in Cdk5 MEFs, resulting in elevated [Ca]. Elevated [Ca] in these cells further induces the production of reactive oxygen species (ROS), which upregulates the levels of Nrf2 and its targets, Prx1 and Prx2. Cdk5 MEFs, which have elevated [Ca], proliferate at a faster rate compared to wt, and Cdk5 embryos have increased body weight and size compared to their wt littermates. Taken together, we show that altered IP3R1-mediated Ca dynamics due to Cdk5 loss correspond to accelerated cell proliferation that correlates with increased body weight and size in Cdk5 embryos.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402492PMC
http://dx.doi.org/10.1007/s00018-022-04515-8DOI Listing

Publication Analysis

Top Keywords

cdk5
14
cdk5 mefs
12
elevated [ca]
12
ip3r1-mediated dynamics
8
cell proliferation
8
dynamics cdk5
8
loss cdk5
8
release internal
8
internal stores
8
ser phosphorylation
8

Similar Publications

The infiltration of glioblastoma multiforme (GBM) is predominantly characterized by diffuse spread, contributing significantly to therapy resistance and recurrence of GBM. In this study, we reveal that microtubule deacetylation, mediated through the downregulation of fibronectin type III and SPRY domain-containing 1 (FSD1), plays a pivotal role in promoting GBM diffuse infiltration. FSD1 directly interacts with histone deacetylase 6 (HDAC6) at its second catalytic domain, thereby impeding its deacetylase activity on α-tubulin and preventing microtubule deacetylation and depolymerization.

View Article and Find Full Text PDF

Mechanisms by which Ganglioside GM1, a specific type of glycosphingolipid, ameliorates BMAA-induced neurotoxicity in early-life stage of zebrafish embryos.

Food Res Int

January 2025

State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, Qingdao 266404, China; Qingdao Marine Science and Technology Center, Qingdao, Shandong Province 266235, China.

The neurotoxin β-methylamino-L-alanine (BMAA) produced by cyanobacteria is widely present in foods and dietary supplements, posing a significant threat to human health. Ganglioside GM1 (GM1) has demonstrated potential for treating neurodegenerative diseases; however, its ability to prevent BMAA-induced neurotoxicity remains uncertain. In this study, zebrafish embryos were treated with Ganglioside GM1 to investigate its neuroprotective effects against BMAA exposure and the underlying mechanisms.

View Article and Find Full Text PDF

Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer's disease.

Alzheimers Res Ther

January 2025

Section of Medical Protein Chemistry, Department of Translational Medicine, Lund University, Malmö, 214-28, Sweden.

We have previously demonstrated that the intracellular, non-GPI anchored CD59 isoforms IRIS-1 and IRIS-2 (Isoforms Rescuing Insulin Secretion 1 and 2) are necessary for insulin secretion from pancreatic β-cells. While investigating their expression across human tissues, we identified IRIS-1 and IRIS-2 mRNA in the human brain, though their protein expression and function remained unclear. This study shows the presence of both IRIS-1 and 2 proteins in the human brain, specifically in neurons and astrocytes.

View Article and Find Full Text PDF

MST2 (STK3) is a major upstream kinase in the Hippo signalling pathway, an evolutionary conserved pathway in regulation of organ size, self-renewal and tissue homeostasis. Its downstream effectors are the transcriptional regulators YAP and TAZ. This pathway is regulated by a variety of factors, such as substrate stiffness or cell-cell contacts.

View Article and Find Full Text PDF

Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment.

Protein Pept Lett

December 2024

Department of Pharm. Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.

Alzheimer's disease (AD) treatments currently available have ineffective results. Previously employed Acetylcholine esterase inhibitors and memantine, an NMDA receptor antagonist, target a single target structure that plays a complex role in the multifactorial progression of disease. Memantine moderates the toxic effects of excessive glutamate activity by blocking NMDA receptors, which decreases neurotoxicity in AD, while acetylcholine esterase inhibitors function by blocking cholinergic receptors (muscarinic and nicotinic), preventing the breakdown of acetylcholine, thereby enhancing cholinergic transmission, thus improving cognitive functions in mild to moderate stages of AD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!